Weekly outlook: Barclays, BAT and GSK report while Fed decides on rates

The key events for UK wealth manager for the week starting 26 July

|

Monday 26 July

-First-half results from newspaper group Reach

-Trading statement from Cranswick

-First-quarter results from Ryanair

-German Ifo industrial confidence survey

-Belgian Courbe Synthetique industrial confidence survey

-In Europe, quarterly results from LVMH, Philips and Logitech

-In the US, quarterly results from Hasbro

Tuesday 27 July

-Full-year results from First Group, Moonpig and Games Workshop

-First-half results from Reckitt Benckiser and Croda

-US durable goods orders

-US S&P/Case-Shiller house price index

-US Conference Board consumer confidence index

-In Europe, quarterly results from Gucci-owner Kering, Moncler and ASM International

-In the US, quarterly results from UPS, Texas Instruments, McDonalds, Starbucks, 3M, Lockheed Martin, Stryker and Freeport McMoRan

Wednesday 28 July

-Barclays’ first-half results

AJ Bell said banking shares have just started to come under pressure in the past month, even though the Bank of England has removed any final restrictions on dividends and buybacks, even though the economy is unlocking and even though analysts have been busily upgrading 2021 profit forecasts for the big lenders.

“As a result, Barclays’ shares are down by a sixth from their year high even if they are up by just under a third compared to a year ago. Given the importance of banks to the economy, and the amount of debt that continues to accumulate in the financial system, the slide in banks’ share prices is a trend that must be watched.”

-British American Tobacco first-half results

BAT chief executive Jack Bowles upgraded expectations for 2021 thanks to accelerating sales of its Vuse, Vype and glo next-generation products, noted AJ Bell. “The CEO also flagged improved cigarette volumes in emerging markets and market share gains and price increases in developed arenas, notably the USA.”

-Glaxosmithkline first-half results

“The key areas of focus remain infectious diseases, HIV, oncology and immunology/respiratory and analysts will scour the first-half statement for progress in the company’s Phase I, II and III clinical trials across its portfolio,” said AJ Bell.

“Shareholders will also look to Glaxosmithkline for any changes to the full-year guidance given alongside its first-quarter results back in April.”

-First-half results from Rio Tinto, Smurfit Kappa, ITV, Aston Martin Lagonda, Foxtons, Card Factory and Dignity

-Interest rate decision from the US Federal Reserve

-US oil inventory data

-In Europe, quarterly results from Christian Dior, BASF, Banco Santander, Vivendi, STMicroelectronics and Deutsche Bank

-In the US, quarterly results from Facebook, Visa, Pfizer, Qualcomm, Boeing, AMD and Ford

Thursday 29 July

-First-half results from Royal Dutch Shell, Lloyds, Astrazeneca, BAE Systems, Johnson Matthey, Diageo, Compass, Smith & Nephew, Sage and SEGRO

-First-quarter results from BT

-UK mortgage approvals and net lending data

-US Q2 GDP growth

-US weekly unemployment claims

-In Asia, quarterly results from Budweiser Asia Pacific, Samsung Electronics and Baidu

-In Europe, quarterly results from AB InBev, Nestlé, L’Oreal, Volkswagen, Total, Sanofi, Danone, Electricité de France, ArcelorMittal, Nokia and Credit Suisse

-In the US, quarterly results from Amazon, Alphabet, Mastercard, Comcast, Intel, Altria, Newmont Mining, KKR and Hershey

Friday 30 July

-First-half results from International Consolidated Airlines, NatWest, Intertek, Rightmove and Pearson

-Japanese unemployment figures

-US PCE indices

-In Japan, quarterly results from Toyota and Japan Tobacco

-In Europe, quarterly results from Hermes, Schneider and Swatch

-In the US, quarterly results from Berkshire Hathaway, Procter & Gamble, ExxonMobil, Caterpillar, Chevron and Pinterest

 

 

MORE ARTICLES ON